IIL Launches India’s first gE deleted DIVA Marker Vaccine against IBR

India’s First gE Deleted DIVA IBR Vaccine Launched

Estimated Reading Time: 2–3 Minutes

Key Takeaways

• Groundbreaking Innovation: IIL has introduced India’s first gE deleted DIVA marker vaccine for Bovine Viral Diarrhea (BVD).
• Enhanced Disease Management: This vaccine enables differentiation between vaccinated and infected animals, improving disease control.
• Improved Herd Health: The vaccine offers a significant advancement in protecting cattle herds from the damaging effects of BVD.

A New Era for Cattle Health in India

Intervet India Limited (IIL) is proud to announce a major breakthrough in animal health with the launch of India’s first gE deleted DIVA marker vaccine against Bovine Viral Diarrhea (BVD). This innovative vaccine represents a significant step forward in the fight against one of the most persistent and economically damaging diseases affecting cattle populations across the country.

The key feature of this new vaccine is its gE deletion and DIVA (Differentiating Infected from Vaccinated Animals) capability. This allows veterinarians and farmers to accurately distinguish between animals that have been vaccinated and those that have been naturally infected with the BVD virus. This distinction is crucial for effective disease surveillance, eradication programs, and overall herd management strategies.

BVD is a widespread viral infection that can lead to a range of severe health problems in cattle, including respiratory issues, reproductive failures, and reduced productivity. The introduction of a vaccine that not only protects against the disease but also aids in its diagnosis will be invaluable for the agricultural sector. It offers a more targeted and efficient approach to controlling outbreaks and safeguarding the health and economic viability of cattle farms.

This launch underscores IIL’s commitment to bringing cutting-edge animal health solutions to the Indian market. By providing tools that facilitate better disease monitoring and control, IIL aims to contribute significantly to the improvement of cattle health, productivity, and the overall sustainability of the dairy and beef industries in India.

Conclusion

IIL’s launch of India’s first gE deleted DIVA marker vaccine against BVD is a monumental achievement for cattle health. Share this exciting news and let us know your thoughts on its potential impact!